These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29217782)

  • 1. Rational management approach to pure red cell aplasia.
    Balasubramanian SK; Sadaps M; Thota S; Aly M; Przychodzen BP; Hirsch CM; Visconte V; Radivoyevitch T; Maciejewski JP
    Haematologica; 2018 Feb; 103(2):221-230. PubMed ID: 29217782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.
    Fujishima N; Sawada K; Hirokawa M; Oshimi K; Sugimoto K; Matsuda A; Teramura M; Karasawa M; Arai A; Yonemura Y; Nakao S; Urabe A; Omine M; Ozawa K;
    Haematologica; 2008 Oct; 93(10):1555-9. PubMed ID: 18641028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H).
    Ru X; Liebman HA
    Br J Haematol; 2003 Oct; 123(2):278-81. PubMed ID: 14531909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia.
    Au WY; Lam CC; Chim CS; Pang AW; Kwong YL
    Leuk Res; 2005 Oct; 29(10):1213-5. PubMed ID: 16111536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathophysiology of pure red cell aplasia: implications for therapy.
    Charles RJ; Sabo KM; Kidd PG; Abkowitz JL
    Blood; 1996 Jun; 87(11):4831-8. PubMed ID: 8639856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group.
    Hirokawa M; Sawada K; Fujishima N; Nakao S; Urabe A; Dan K; Fujisawa S; Yonemura Y; Kawano F; Omine M; Ozawa K;
    Haematologica; 2008 Jan; 93(1):27-33. PubMed ID: 18166782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study.
    Verhelst D; Rossert J; Casadevall N; Krüger A; Eckardt KU; Macdougall IC
    Lancet; 2004 May; 363(9423):1768-71. PubMed ID: 15172775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory pure red cell aplasia associated with B-CLL: successful treatment with a combination of fludarabine, cyclosporin A and erythropoietin.
    Shimoni A; Shvidel L; Klepfish A; Shtalrid M; Sigler E; Berrebi A
    Leukemia; 1999 Jan; 13(1):142-3. PubMed ID: 10049051
    [No Abstract]   [Full Text] [Related]  

  • 9. [The efficacy of alemtuzumab for pure red cell aplasia associated with autoimmune polyendocrine syndrome type 1].
    Sato M; Shino M; Yokoyama K; Ishida T; Hirao M; Kamoda Y; Iizuka H; Kida M; Imoto S; Tojo A; Usuki K
    Rinsho Ketsueki; 2022; 63(3):189-193. PubMed ID: 35387931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose subcutaneous alemtuzumab is a safe and effective treatment for chronic acquired pure red cell aplasia.
    Chow JK; Chan TK
    Hong Kong Med J; 2013 Dec; 19(6):549-52. PubMed ID: 24310664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic outcomes using subcutaneous low dose alemtuzumab for acquired bone marrow failure conditions.
    Thota S; Patel BJ; Sadaps M; Balasubramanian S; Sanikommu S; Hirsch C; Marotta S; Sekeres MA; Risitano AM; Maciejewski JP
    Br J Haematol; 2018 Oct; 183(1):133-136. PubMed ID: 28905372
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of thymoma-associated pure red cell aplasia with intravenous immunoglobulins.
    Larroche C; Mouthon L; Casadevall N; Le Roux G; Casassus P; Guillevin L
    Eur J Haematol; 2000 Jul; 65(1):74-6. PubMed ID: 10914943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alemtuzumab-induced red cell aplasia and other immune cytopenias: not so 'pure'.
    Aitken L; Patel R; D'Rozario J; Choi P
    Immunotherapy; 2022 Feb; 14(2):95-99. PubMed ID: 34743591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct effect of cyclophosphamide and cyclosporine on pure red cell aplasia associated with T-cell large granular lymphocyte leukemia.
    Tabata R; Tabata C
    Int Immunopharmacol; 2014 Dec; 23(2):391-4. PubMed ID: 25466263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and outcomes of 11 patients with pure red cell aplasia at a single institution over a 13-year period.
    Kawano N; Nagahiro Y; Yoshida S; Yamashita K; Himeji D; Yokota-Ikeda N; Uezono S; Shimao Y; Makino S; Shimoda K; Ueda A
    Intern Med; 2013; 52(18):2025-30. PubMed ID: 24042508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete resolution of pure red cell aplasia in a patient with chronic lymphocytic leukemia following antithymocyte globulin therapy.
    Radosevich CA; Gordon LI; Weil SC; Marder RJ; Rosen ST
    JAMA; 1988 Feb; 259(5):723-5. PubMed ID: 3121873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of pure red cell aplasia accompanied with granular lymphocytic leukemia the tumor cells of which suppressed colony formation of BFU-E, and which was successfully treated by cyclophosphamide and cyclosporin A].
    Hirayama Y; Nagai T; Ohta H; Koyama R; Matsunaga T; Sakamaki S; Niitsu Y
    Rinsho Ketsueki; 1997 Nov; 38(11):1206-11. PubMed ID: 9423339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathophysiology and treatment of large granular lymphocyte leukemia-associated pure red cell aplasia].
    Fujishima N
    Rinsho Ketsueki; 2010 Aug; 51(8):589-96. PubMed ID: 20805663
    [No Abstract]   [Full Text] [Related]  

  • 19. Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities.
    Lacy MQ; Kurtin PJ; Tefferi A
    Blood; 1996 Apr; 87(7):3000-6. PubMed ID: 8639922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythroblastopenia: chronic idiopathic or associated with chronic lymphoid leukemia. Value of cultures of erythroblastic progenitors and therapeutic strategy].
    Casadevall N; Lacombe C; Varet B
    Presse Med; 1993 Jun; 22(23):1079-86. PubMed ID: 8415459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.